Epstein Barr virus specific cytotoxic T lymphocytes expressing the anti-CD30zeta artificial chimeric T-cell receptor for immunotherapy of Hodgkin disease.
about
Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigenRecent advances in the management of Hodgkin lymphomaNovel immunotherapies in lymphoid malignanciesAdoptive T-Cell ImmunotherapyThe role of autologous and allogeneic hematopoietic stem cell transplantation for Hodgkin lymphomaDeveloping strategies in the immunotherapy of leukemiasManufacture of tumor- and virus-specific T lymphocytes for adoptive cell therapiesIn Vitro Pre-Clinical Validation of Suicide Gene Modified Anti-CD33 Redirected Chimeric Antigen Receptor T-Cells for Acute Myeloid LeukemiaVirus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastomaEngineered T cells for cancer treatmentStrategies to genetically engineer T cells for cancer immunotherapy.Immunotherapy in acute leukemiaDerivation of human T lymphocytes from cord blood and peripheral blood with antiviral and antileukemic specificity from a single culture as protection against infection and relapse after stem cell transplantationCombining CD19 redirection and alloanergization to generate tumor-specific human T cells for allogeneic cell therapy of B-cell malignancies.The future is now: chimeric antigen receptors as new targeted therapies for childhood cancerSuccessful eradication of established peritoneal ovarian tumors in SCID-Beige mice following adoptive transfer of T cells genetically targeted to the MUC16 antigen.Adoptive cell transfer as personalized immunotherapy for human cancer.The interplay between Epstein-Barr virus and the immune system: a rationale for adoptive cell therapy of EBV-related disordersImmunotherapy of human cancers using gene modified T lymphocytes.NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell TransplantatioAnti-GD2 Strategy in the Treatment of NeuroblastomaThe innovative evolution of cancer gene and cellular therapies.Towards gene therapy for EBV-associated posttransplant lymphoma with genetically modified EBV-specific cytotoxic T cells.Genetically engineered T cells for the treatment of cancer.Antibody-based immunotherapy in high-risk neuroblastoma.The promise and potential pitfalls of chimeric antigen receptors.In vitro and in vivo model of a novel immunotherapy approach for chronic lymphocytic leukemia by anti-CD23 chimeric antigen receptor.Antigen presenting cell-mediated expansion of human umbilical cord blood yields log-scale expansion of natural killer cells with anti-myeloma activity.Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastomaGeneration of CD19-chimeric antigen receptor modified CD8+ T cells derived from virus-specific central memory T cellsIn Vitro and In Vivo Antitumor Effect of Anti-CD33 Chimeric Receptor-Expressing EBV-CTL against CD33 Acute Myeloid LeukemiaCMVpp65 Vaccine Enhances the Antitumor Efficacy of Adoptively Transferred CD19-Redirected CMV-Specific T Cells.K562-Derived Whole-Cell Vaccine Enhances Antitumor Responses of CAR-Redirected Virus-Specific Cytotoxic T Lymphocytes In Vivo.Co-expression of cytokine and suicide genes to enhance the activity and safety of tumor-specific cytotoxic T lymphocytes.Genetically modified T-cell therapy for osteosarcomaChallenges and opportunities of allogeneic donor-derived CAR T cellsGenetic modification of human T lymphocytes for the treatment of hematologic malignancies.Immunotherapy of malignant disease using chimeric antigen receptor engrafted T cellsThe Promise of Chimeric Antigen Receptor Engineered T Cells in the Treatment of Hematologic MalignanciesClinical targeting of the TNF and TNFR superfamilies
P2860
Q24623215-BF13E101-5853-4DE1-8D45-DA504FAAC735Q26751214-E6C8BD56-2FA4-40E0-8666-9208BD3E8767Q26777394-B9BEDD32-D727-4BBA-B7D2-77FF080AE6C0Q26782845-C4762016-539C-4B30-8449-21B45A903910Q26822480-12F896E9-41F0-4B40-A423-FF7FCF396A26Q26996310-38F24C32-B851-4D50-B1B7-9BB7CDD065CBQ28085769-D3B747E5-414C-4844-B83E-73F75FFB9376Q28554677-16A5908A-5D00-4C8E-9F0F-331342422869Q29622835-CB910196-876F-4040-A917-925422BE8B17Q33578792-0DC6BE56-823D-464D-9EB2-3223AD18870BQ33655849-0D2B6D19-DB34-47AF-BE17-2A450A45A5D0Q33731552-D9499DAA-33E4-4524-A449-AED60F16ECF5Q33780277-0DE8587F-10DC-45A6-BD5F-6A419E37C240Q33862876-B7322880-B7DD-4A95-B605-C3E94B5EDBA0Q33993529-45DAAA61-C267-4FBD-A029-F620049E543BQ34007762-BD9148C3-3FA4-4F61-8844-D9DEEAD30735Q34043643-9C579B01-6A59-4611-BCF2-E0BCFE7D3A2DQ34166602-EFAF0BE3-73D4-4324-8B42-8C7187EC23DCQ34188383-CF03DA66-AC13-4D99-8CBA-B9184E6C9EA5Q34202277-79374911-6A32-4A25-8F40-AC32768AD7B1Q34243887-3CE29F8C-11F0-434B-8869-9068D012B3F0Q34325544-AF3BBF0A-27A2-4126-9711-55F164183E91Q34353696-F5103EC0-A152-4CB1-A36C-0E92DF05E8F3Q34645898-B1583D3A-9BD7-4B88-88BC-33CD34866E4AQ34725758-33F5A81E-2A46-44F4-B8E4-09BA39525A8EQ34970378-8E2523EF-2081-4E59-BB66-A7011BC64925Q35001579-9A7B8AC9-4D9D-4AF9-A009-4D8609D578DBQ35034803-70DFE3B8-AED2-45FF-954A-FD0C5598D9DAQ35604043-934C7054-210D-447A-BFEF-F720460AB289Q35651760-B64D26CC-F81B-415A-A24E-F64EEDA34641Q35681332-AA6E3966-586F-451B-9361-6863657B90F0Q35811921-B2095BC0-3372-41A9-B637-4471FE905780Q35812085-DEBC8E7A-468E-45B8-9825-9DE4F0F05743Q36059585-4B89A5F6-26BB-40BB-B0DC-806FE1D0054CQ36198232-30E2C894-8450-42E4-98A2-93F4B7FF7DBEQ36257036-21D84DBA-B64F-4E2F-96D7-55661722552FQ36366557-49E08772-68A7-4967-9908-DCDC14F9A418Q36470354-5F4DC7EF-219C-467C-AA6C-A41704D58FCFQ36547199-AF814A2B-A480-436D-8FFE-CFE97142B051Q36762882-2EB76EDA-D13D-4418-A392-19519E984470
P2860
Epstein Barr virus specific cytotoxic T lymphocytes expressing the anti-CD30zeta artificial chimeric T-cell receptor for immunotherapy of Hodgkin disease.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Epstein Barr virus specific cy ...... unotherapy of Hodgkin disease.
@ast
Epstein Barr virus specific cy ...... unotherapy of Hodgkin disease.
@en
type
label
Epstein Barr virus specific cy ...... unotherapy of Hodgkin disease.
@ast
Epstein Barr virus specific cy ...... unotherapy of Hodgkin disease.
@en
prefLabel
Epstein Barr virus specific cy ...... unotherapy of Hodgkin disease.
@ast
Epstein Barr virus specific cy ...... unotherapy of Hodgkin disease.
@en
P2093
P2860
P921
P1433
P1476
Epstein Barr virus specific cy ...... unotherapy of Hodgkin disease.
@en
P2093
Aaron E Foster
Andreas Hombach
Antonio Di Stasi
Barbara Savoldo
Cliona M Rooney
Gianpietro Dotti
Helen E Heslop
Hinrich Abken
Malcolm K Brenner
P2860
P304
P356
10.1182/BLOOD-2006-11-059139
P407
P577
2007-05-16T00:00:00Z